Drs Edelman and Fleisher on Personalizing and Adapting Treatment Approaches in Clinical Trials - Stand Up To Cancer

News

Drs Edelman and Fleisher on Personalizing and Adapting Treatment Approaches in Clinical Trials

Martin Edelman, MD, and Linda Fleisher, PhD, MPH, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.